Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
JoVE Journal
Cancer Research

A subscription to JoVE is required to view this content.

Paramyxovirus for Tumor-målrettet Immunomodulation
 
Click here for the English version

Paramyxovirus for Tumor-målrettet Immunomodulation: Design og evaluering Ex Vivo

Article DOI: 10.3791/58651-v 12:42 min January 7th, 2019
January 7th, 2019

Chapters

Summary

Please note that all translations are automatically generated.

Click here for the English version.

Denne protokol beskriver en detaljeret arbejdsgang for generation og ex vivo karakterisering af oncolytic virus for udtryk for hæmmende, ved hjælp af mæslinger virus kodning bispecific T-celle ager som eksempel. Ansøgning og tilpasning til andre vektor platforme og transgener vil fremskynde udviklingen af nye immunovirotherapeutics for klinisk oversættelse.

Tags

Kræftforskning spørgsmålet 143 Oncolytic virotherapy cancer immunterapi virale vektorer mæslingevirus paramyxovirus bispecific T-celle engager
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter